marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Corvus Pharmaceuticals Kennzahlen 2011-2024 | CRVS
Kennzahlen Jährlich Corvus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.5 | -0.7 | -1.7 | -17.1 | -3.5 | -2.3 | -3.4 | -5.9 | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.6 | -0.9 | -1.0 | -0.2 | -1.6 | -1.7 | -2.7 | -2.4 | -83.9 | -0.9 | - | - | - |
EV (Enterprise Value) |
88.4 M | 29.7 M | 22.9 M | 99.5 M | 169 M | 76 M | 155 M | 216 M | 125 M | 171 K | - | - | - |
EBITDA per Share |
-0.48 | -0.69 | -0.91 | -1.46 | -1.64 | -1.76 | -2.72 | -2.36 | - | - | - | - | - |
EV/EBITDA |
0.2 | -2.2 | -3.2 | -1.4 | -2.6 | -5.7 | - | - | - | - | - | ||
PEG |
0.16 | 0.03 | 0.11 | -0.21 | -0.49 | -0.06 | 0.22 | 0.11 | - | - | - | - | - |
P/B |
2.4 | 0.5 | 0.8 | 1.4 | 2.3 | 1.0 | 2.2 | 1.6 | - | - | - | - | - |
P/CF |
-3.9 | -1.1 | -2.0 | -2.9 | -4.3 | -2.6 | -4.1 | -7.1 | - | - | - | - | - |
ROE % |
-69.87 | -73.61 | -44.50 | -8.31 | -65.63 | -42.54 | -65.61 | -27.39 | - | - | - | - | - |
ROA % |
-59.34 | -60.53 | -39.51 | -7.01 | -55.80 | -39.70 | -58.73 | -25.95 | - | - | - | - | - |
ROCE % |
-60.51 | -58.03 | -39.76 | -60.65 | -66.54 | -44.26 | -65.87 | -27.55 | - | - | - | - | - |
Current Ratio |
6.6 | 5.6 | 8.9 | 6.4 | 7.8 | 16.4 | 10.2 | 22.9 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Corvus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.6 | -0.07 | -0.12 | - | -0.12 | -0.14 | -0.17 | - | -0.32 | -0.18 | -0.18 | -0.2 | -0.24 | -0.28 | -0.34 | 0.92 | -0.33 | -0.36 | -0.44 | -0.38 | -0.37 | -0.44 | -0.4 | -0.36 | -0.36 | -0.4 | -0.63 | -0.58 | -0.62 | -0.73 | -0.79 | -0.55 | -0.51 | -0.43 | -5.39 | -13.31 | -7.97 | -58.42 | -6.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.11 | -0.1 | -0.13 | - | -0.11 | -0.12 | -0.14 | - | -0.27 | -0.15 | -0.16 | - | -0.2 | -0.26 | -0.33 | - | -0.32 | -0.35 | -0.44 | - | -0.37 | -0.45 | -0.41 | - | -0.36 | -0.41 | -0.64 | - | -0.6 | -0.72 | -0.79 | - | -0.5 | -0.43 | -5.37 | - | -7.66 | -6.63 | -7.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-363.05 | -52.50 | -57.32 | -42.80 | -65.73 | -75.11 | -72.37 | -42.58 | -52.73 | -39.95 | -41.74 | -34.61 | 3.29 | -0.13 | -2.65 | -8.31 | -61.75 | -63.64 | -67.19 | -65.63 | -59.62 | -53.66 | -45.95 | -42.54 | -47.08 | -52.55 | -59.67 | -65.61 | -59.90 | -52.66 | -41.51 | -27.39 | 0.37 | 18.26 | 89.82 | 100.75 | 81.34 | 71.20 | 6.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-100.75 | -43.93 | -48.53 | -36.28 | -54.74 | -61.65 | -59.48 | -35.69 | -44.63 | -35.12 | -36.82 | -30.29 | 1.69 | -0.82 | -2.49 | -7.01 | -52.19 | -53.89 | -57.00 | -55.80 | -51.48 | -47.20 | -41.52 | -39.70 | -43.40 | -47.94 | -53.91 | -58.73 | -54.06 | -47.98 | -38.35 | -25.95 | -24.18 | -20.03 | -34.41 | -31.83 | -25.69 | -22.49 | -1.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-101.35 | -55.44 | -55.21 | -37.37 | -56.65 | -63.38 | -60.74 | -36.27 | -44.87 | -34.19 | -37.18 | -32.48 | -46.13 | -51.17 | -54.38 | -46.96 | -63.15 | -65.70 | -69.89 | -52.61 | -62.72 | -56.63 | -48.62 | -34.49 | -49.74 | -54.90 | -61.67 | -52.26 | -60.15 | -52.78 | -41.54 | -19.37 | -9.34 | 8.58 | 22.72 | 24.65 | 24.65 | 14.62 | 7.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 4.8 | 6.0 | 6.6 | 6.8 | 6.8 | 6.2 | 5.6 | 5.1 | 7.6 | 8.8 | 8.9 | 8.4 | 8.4 | 7.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.7 | 6.7 | 6.7 | 6.7 | 15.0 | 15.0 | 15.0 | 15.0 | 9.5 | 9.5 | 9.5 | 9.5 | 19.1 | 19.1 | 19.1 | 19.1 | 26.1 | 26.1 | 26.1 | 26.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung